Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Russia

- PMLiVE

Intellectual property threats in the BRIC markets

Compulsory licensing and other legal concerns for pharma in emerging markets

- PMLiVE

The rise of chronic disease in BRIC markets

Changing disease patterns in the BRIC nations are providing new opportunities for growth

- PMLiVE

A tailored approach to the BRIC markets

Patience, long-term thinking and strategies that are tailored to each market are key to pharma success in the BRIC countries and other emerging markets

- PMLiVE

Building BRICs: pharma’s key emerging markets are becoming giants

The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon need to relinquish their 'emerging' tag and...

- PMLiVE

Eisai expands into Russia with Halaven launch

Breast cancer drug will be followed by epilepsy portfolio

Ogilvy Commonhealth Worldwide open Moscow offices

Will focus on pharmaceutical and healthcare market in Russia

- PMLiVE

New US Coca-Cola ad while Russia tightens food legislation

Soft drinks giant launches low-cal ad in US while Russia plans tough legislation on fast food advertising and labelling, as pressure on fast food companies grows

- PMLiVE

Lilly pays $29m to settle foreign bribery charges

US Securities and Exchange Commission charges centre on activities in Russia, China, Brazil and Poland

- PMLiVE

Takeda completes new manufacturing facility in Russia

Expands Japanese firm’s presence in key emerging market

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links